Novartis takes Xolair follow-up into phase III hives trialNovartis says it intends to move a drug for chronic spontaneous urticaria (CSU), a severe form of hives, Share XNovartis takes Xolair follow-up into phase III hives trialhttps://pharmaphorum.com/news/novartis-takes-xolair-follow-up-into-phase-iii-hives-trial/
